口内乾燥症治療薬の世界市場2019-2023

◆英語タイトル:Global Xerostomia Therapeutics Market 2019-2023
◆商品コード:IRTNTR30455
◆発行会社(リサーチ会社):Technavio
◆発行日:2018年12月7日
◆ページ数:112
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、口内乾燥症治療薬の世界市場について調査・分析し、市場概要、市場環境、口内乾燥症治療薬市場規模、製品別(市販薬、処方薬)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・口内乾燥症治療薬の世界市場概要
・口内乾燥症治療薬の世界市場環境
・口内乾燥症治療薬の世界市場動向
・口内乾燥症治療薬の世界市場規模
・口内乾燥症治療薬の世界市場:業界構造分析
・口内乾燥症治療薬の世界市場:製品別(市販薬、処方薬)
・口内乾燥症治療薬の世界市場:地域別市場規模・分析
・口内乾燥症治療薬の北米市場規模・予測
・口内乾燥症治療薬のヨーロッパ・中東・アフリカ市場規模・予測
・口内乾燥症治療薬のアジア太平洋市場規模・予測
・口内乾燥症治療薬の主要国分析
・口内乾燥症治療薬の世界市場:意思決定フレームワーク
・口内乾燥症治療薬の世界市場:成長要因、課題
・口内乾燥症治療薬の世界市場:競争環境
・口内乾燥症治療薬の世界市場:関連企業情報(ベンダー分析)

主な分析対象企業は、Colgate-Palmolive、DAIICHI SANKYO、Eisai、GlaxoSmithKline、and ORAHEALTHなどです。
【レポートの概要】

About this market
The most common disease that causes xerostomia is an inflammatory autoimmune disease. Additionally, central nervous system- related diseases including stress, depression, and anxiety can also lead to xerostomia. Moreover, trauma to the head and neck area can alter the nerve stimuli to the mouth and impair the function to the salivary glands. Therefore, the rising incidence of the health conditions or diseases that are high- risk factors for xerostomia is expected to continue to support the growth of the global xerostomia therapeutics market during the forecast period. According to our industry experts, the xerostomia therapeutics market to grow at a CAGR of over 3% during the forecast period.
Market Overview
Growing geriatric population
The increasing number of people with xerostomia is directly related to the growing geriatric population. The number of old people worldwide has been growing significantly over the years. This expected to contribute significantly to the market as this high growth in the older population helps to drive the sales of various therapeutics markets during our forecast period.
Product recalls and tedious drug approval process
Regulatory bodies have framed stringent regulations to grant marketing approval for therapeutics that are being newly developed for the treatment of xerostomia. Many applications rejected either due to the inadequate performance of the drug or because the information on the drug, which is submitted is unsatisfactory. Such stringent government regulations can lead to a delay in drug in drug approval which in turn hampers the growth of the market.
For the detailed list of factors that will drive and challenge the growth of the xerostomia therapeutics market during the 2019-2023, view our report.
Competitive Landscape
The xerostomia therapeutics market is fragmented due to presence of many vendors in the market. The pharmaceutical companies are forming strategic collaborations which will enhance the R&D activities for new drugs for the management xerostomia. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• OTC – Market size and forecast 2018-2023
• Prescription – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
PART 10: VENDOR LANDSCAPE
• Market drivers
• Market challenges
PART 11: TRENDS
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Colgate-Palmolive
• DAIICHI SANKYO
• Eisai
• GlaxoSmithKline
• ORAHEALTH
PART 14: APPENDIX
• Research methodology
• List of abbreviations


Exhibit 01: Years in consideration
Exhibit 02: Global oral hygiene products market
Exhibit 03: Segments of global oral hygiene products market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Product – Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: OTC – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: OTC – Year-over-year growth 2019-2023 (%)
Exhibit 22: Prescription – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Prescription – Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 30: Top 3 countries in Americas
Exhibit 31: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in EMEA
Exhibit 34: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 36: Top 3 countries in APAC
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Decision framework
Exhibit 01: Global prevalence of geriatric population
Exhibit 02: Impact of drivers and challenges
Exhibit 03: Biologics under development for xerostomia
Exhibit 04: Vendor landscape
Exhibit 05: Landscape disruption
Exhibit 06: Vendors covered
Exhibit 07: Vendor classification
Exhibit 08: Market positioning of vendors
Exhibit 09: Colgate-Palmolive – Vendor overview
Exhibit 10: Colgate-Palmolive – Business segments
Exhibit 11: Colgate-Palmolive – Organizational developments
Exhibit 12: Colgate-Palmolive – Geographic focus

Exhibit 13: Colgate-Palmolive – Segment focus
Exhibit 14: Colgate-Palmolive – Key offerings
Exhibit 15: Colgate-Palmolive – Key customers
Exhibit 16: DAIICHI SANKYO – Vendor overview
Exhibit 17: DAIICHI SANKYO – Organizational developments
Exhibit 18: DAIICHI SANKYO – Geographic focus
Exhibit 19: DAIICHI SANKYO – Key offerings
Exhibit 20: DAIICHI SANKYO – Key customers
Exhibit 21: Eisai – Vendor overview
Exhibit 22: Eisai – Business segments
Exhibit 23: Eisai – Organizational developments
Exhibit 24: Eisai – Geographic focus
Exhibit 25: Eisai – Segment focus
Exhibit 26: Eisai – Key offerings
Exhibit 27: Eisai – Key customers
Exhibit 28: GlaxoSmithKline – Vendor overview
Exhibit 29: GlaxoSmithKline – Business segments
Exhibit 30: GlaxoSmithKline – Organizational developments
Exhibit 31: GlaxoSmithKline – Geographic focus
Exhibit 32: GlaxoSmithKline – Segment focus
Exhibit 33: GlaxoSmithKline – Key offerings
Exhibit 34: GlaxoSmithKline – Key customers
Exhibit 35: ORAHEALTH – Vendor overview
Exhibit 36: ORAHEALTH – Organizational developments
Exhibit 37: ORAHEALTH – Key offerings
Exhibit 38: ORAHEALTH – Key customers
Exhibit 39: Validation techniques employed for market sizing
Exhibit 40: List of abbreviations



【掲載企業】

Colgate-Palmolive、DAIICHI SANKYO、Eisai、GlaxoSmithKline、and ORAHEALTH

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[口内乾燥症治療薬の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆